autologous peripheral blood-derived stem cell therapy (Taipei Medical University Hospital)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameautologous peripheral blood-derived stem cell therapy (Taipei Medical University Hospital)
Drug Alias Nameautologous stem cell therapy (Taipei Medical University Hospital)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Osteogenic potential stem cell therapy
Mechanisms of ActionBone synthesis stimulants
TargetsUpdating
Therapy Area/IndicationsFractures, Bone
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTaipei Medical University Hospital
China Registration ClassN/A

Develop Information

Active CompaniesTaipei Medical University Hospital
Inactive CompaniesN/A
Active IndicationsFractures, Bone
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A